期刊： MEDICAL ONCOLOGY, 2023; 40 (5)
Aside from the high prevalence of incidents of breast cancer, the high grade of heterogeneity and the dearth of standard treatment guidelines make tri......
期刊： MEDICAL ONCOLOGY, 2023; 40 (6)
Triple-negative breast cancer (TNBC) is highly heterogeneous in the stromal and immune microenvironment, genome integrity, oncogenic signatures, and m......
期刊： MEDICAL ONCOLOGY, 2023; 40 (6)
Advances in nuclear medicine, such as single photon emission computed tomography (SPECT) and positron emission tomography (PET), are among the most se......
期刊： MEDICAL ONCOLOGY, 2023; 40 (7)
Traditional Chinese medicine (TCM) has been widely used for cancer treatment. Identification of anti-cancer targets of TCM is the first and principal ......
期刊： MEDICAL ONCOLOGY, 2023; 40 (8)
Cancer treatment is one of the most challenging topics in medical sciences. Different methods such as chemotherapy, tumor surgery, and immune checkpoi......
期刊： MEDICAL ONCOLOGY, 2023; 40 (9)
Drug resistance is one of the clinical challenges that limits the effectiveness of chemotherapy. Recent reports suggest that the unfolded protein resp......
期刊： MEDICAL ONCOLOGY, 2023; 40 (10)
Chemo-resistance has been identified as a crucial factor contributing to tumor recurrence and a leading cause of worse prognosis in patients with ESCC......
期刊： MEDICAL ONCOLOGY, 2023; 40 (11)
Human T-cell lymphotropic virus type 1 (HTLV-1) is the first identified human retrovirus responsible for two significant diseases: HTLV-1-associated m......
期刊： MEDICAL ONCOLOGY, 2023; 40 (11)
Combination therapy has been frequently preferred in treating various types of cancer in recent years. Targeted cancer therapy has also become one of ......
期刊： MEDICAL ONCOLOGY, 2023; 40 (2)
Objective Ovarian cancer is the seventh most common cancer in women, and it causes many deaths in women worldwide. Patients with ovarian cancer have a......
期刊： MEDICAL ONCOLOGY, 2023; 40 (7)
Monensin is an ionophore antibiotic isolated from Streptomyces cinnamonensis with very strong antibacterial and antiparasitic effects. Although monens......
期刊： MEDICAL ONCOLOGY, 2023; 40 (7)
Invasive mucinous adenocarcinoma (IMA) is a rare variant of adenocarcinoma with unique clinical, radiological, and pathological features, among which ......
期刊： MEDICAL ONCOLOGY, 2023; 40 (7)
Colorectal cancer (CRC) is a prevalent gastrointestinal neoplasm that ranks fourth in terms of cancer-related deaths worldwide. In the process of CRC ......
期刊： MEDICAL ONCOLOGY, 2023; 40 (9)
Although triple-negative breast cancer accounts for less than one-fifth of breast cancers, it has a higher rate of metastasis and mortality. This stud......
期刊： MEDICAL ONCOLOGY, 2023; 40 (5)
Pathogen-based cancer vaccine is a promising immunotherapeutic weapon to stimulate cancer immunosuppressive state. Toxoplasma gondii is a potent immun......
